Accessibility Menu
Greenwich LifeSciences Stock Quote

Greenwich LifeSciences (NASDAQ: GLSI)

$8.99
(-1.9%)
-0.17
Price as of October 22, 2025, 12:46 p.m. ET

KEY DATA POINTS

Current Price
$8.95
Daily Change
(-1.9%) $0.17
Day's Range
$8.95 - $9.26
Previous Close
$9.16
Open
$9.16
Beta
1.18
Volume
76,991
Average Volume
63,723
Market Cap
124.9M
Market Cap / Employee
$9.16M
52wk Range
$8.06 - $15.47
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$1.36
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Greenwich LifeSciences Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GLSI-31.59%+118.36%+16.9%+83%
S&P+15.06%+95.03%+14.29%+104%

Greenwich LifeSciences Company Info

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.00M3.0%
Market Cap$121.25M-45.5%
Market Cap / Employee$15.16M0.0%
Employees814.3%
Net Income-$4.03M-54.4%
EBITDA-$4.05M-52.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$3.13M-56.7%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.00M0.0%
Short Term Debt$0.00M0.0%

Ratios

Q2 2025YOY Change
Return On Assets-347.56%-235.1%
Return On Invested Capital-167.75%-175.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$2.23M-113.1%
Operating Free Cash Flow-$2.23M-113.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book31.9629.6325.1791.18110.12%
Price to Tangible Book Value31.9829.6425.1891.24110.07%
Enterprise Value to EBITDA-67.09-17.77-37.46-29.21-63.95%
Return on Equity-151.7%-342.0%-515.3%-491.9%297.79%
Total Debt$0.00M$0.00M$0.00M$0.00M-

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.